fda compounding semaglutide warning september 2025 Beyond the Headlines: Letters to GLP-1 Compounders Semaglutide Safety Alerts, Recalls &

Its very possible its the answer youve been waiting for

When using any transdermal medication, patients should avoid applying a new patch to the same exact location for at least one to two weeks, or as specified in the product labeling

Still, the best outcomes in trials occurred when medication was paired with structured routines, regular logging, and clinician-guided titration to preserve lean mass and manage side effects

And there were only 13 people

As a GLP-1 receptor agonist , Semaglutide mimics natural hormones that regulate hunger and blood sugar levels

The gut-brain axis plays a significant role in digestive and hormonal regulation, and psychological wellbeing may indirectly affect gut hormone production